COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,552 Articles (22,881 medRxiv, 8,671 bioRxiv)

Most recent first Previous |  Page 2805: Articles 28041-28050  | Next

MRI of the lungs in patients with COVID-19: clinical case
Vasilev, Y., Sergunova, K., Bazhin, A., Masri, A., Vasileva, Y., Suleumanov, E., Semenov, D., Kudryavtsev, N., Panina, O., Khoruzhaya, A., Znichenko, V., Akhmad, E., Petraikin, A., Vladzymyrskyy, A., Midaev, A., Morozov, S.
10.1101/2020.05.13.20088732 — Posted: 2020-05-16 Discussion: Onsite
SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design
Kushwaha, S. K., Kesarwani, V., Choudhury, S., Gandhi, S., Sharma, S.
10.1101/2020.05.14.097170 — Posted: 2020-05-15
Analysis of SARS-CoV-2 RNA-Sequences by Interpretable Machine Learning Models
Villmann, T., Kaden, M., Bohnsack, K. S., Weber, M., Kudla, M., Gutowska, K., Blazewicz, J.
10.1101/2020.05.15.097741 — Posted: 2020-05-15
Background mechanisms of olfactory dysfunction in COVID-19: expression of ACE2, TMPRSS2, and Furin in the nose and olfactory bulb in human and mice
Ueha, R., Kondo, K., Kagoya, R., Shichino, S., Ueha, S., Yamasoba, T.
10.1101/2020.05.15.097352 — Posted: 2020-05-15
CoV-AbDab: the Coronavirus Antibody Database
Raybould, M. I. J., Kovaltsuk, A., Marks, C., Deane, C. M.
10.1101/2020.05.15.077313 — Posted: 2020-05-15
Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection
Smith, E., Zhen, W., Manji, R., Schron, D., Duong, S., Berry, G. J.
10.1101/2020.05.14.097311 — Posted: 2020-05-15
SARS-CoV2 (COVID-19) Structural/Evolution Dynamicome: Insights into functional evolution and human genomics.
Gupta, R., Charron, J., Stenger, C., Painter, J., Steward, H., Cook, T., Faber, W., Frisch, A., Lind, E., Bauss, J., Li, X., Sirpilla, O., Soehnlen, X., Underwood, A., Hinds, D., Morris, M., Lamb, N., Carcillo, J., Bupp, C., Uhal, B., Rajasekaran, S., Prokop, J. W.
10.1101/2020.05.15.098616 — Posted: 2020-05-15
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Alum Induces Protective Immunity and Reduces Immune Enhancement
Chen, W.-H., Tao, X., Peng, B.-H., Pollet, J., Strych, U., Bottazzi, M. E., Hotez, P. J., Lustigman, S., Du, L., Jiang, S., Tseng, C.-T. K.
10.1101/2020.05.15.098079 — Posted: 2020-05-15
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
Cai, Y., Yin, D., Ling, S., Tian, X., Li, Y., Xu, Z., Jiang, H., Zhang, X., Wang, X., Shi, Y., Zhang, Y., Da, L., Tao, S.-c., Wang, Q., Xu, J., Ying, T., Hong, J.
10.1101/2020.05.14.093054 — Posted: 2020-05-15 Discussion: Onsite | Offsite
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
Shannon, A., Selisko, B., Le, T.-T.-N., Huchting, J., Touret, F., Piorkowski, G., Fattorini, V., Ferron, F., Decroly, E., Meier, C., Coutard, B., Peersen, O., Canard, B.
10.1101/2020.05.15.098731 — Posted: 2020-05-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).